company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,25891000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,36998000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,832000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,63721000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1403000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,497000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,497000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,,totalassets,Total Assets,=,debit,usd,65621000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3124000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1999000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5780000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,4446000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,15349000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,13815000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,20000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,13835000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,29184000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,411380000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-374953000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,10000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,36437000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,36437000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,36437000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q2,,2011-06-30,2011-08-04 06:18:52+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,65621000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,20643000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,30017000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1362000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,52022000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1316000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,530000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,530000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,,totalassets,Total Assets,=,debit,usd,53868000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,4633000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2921000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6259000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,3303000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,17116000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,12154000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,17000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,12171000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,29287000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,412267000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-387687000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,24581000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,24581000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,24581000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2011.0,Q3,,2011-09-30,2011-11-03 06:14:35+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,53868000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,34550000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,22840000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,608000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,57998000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1324000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,519000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,519000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,,totalassets,Total Assets,=,debit,usd,59841000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,6067000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3040000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6537000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,15644000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,10416000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,11000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,10427000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,26071000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,447232000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-413481000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,19000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,33770000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,33770000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,33770000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q1,,2012-03-31,2012-05-03 06:09:33+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,59841000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,25593000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,19063000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,839000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,45495000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1166000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,503000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,503000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,,totalassets,Total Assets,=,debit,usd,47164000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,7891000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3468000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,6895000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18254000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,8438000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,8000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,8446000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,26700000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,448561000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-428101000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,4000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,20464000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,20464000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,20464000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q2,,2012-06-30,2012-08-02 06:06:35+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,47164000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,29442000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,25697000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,803000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,55942000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1205000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,466000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,466000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,,totalassets,Total Assets,=,debit,usd,57613000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,7913000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3690000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7362000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,18965000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,6454000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,4000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,6458000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,25423000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,475279000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-443097000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,8000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,32190000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,32190000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,32190000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2012.0,Q3,,2012-09-30,2012-11-06 06:05:11+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,57613000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,34962000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,55432000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1475000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,91869000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1350000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,481000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,481000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,,totalassets,Total Assets,=,debit,usd,93700000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,3092000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5719000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7740000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,16551000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,20545000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,20545000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,37096000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,538545000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-481948000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,7000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,56604000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,56604000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,56604000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q1,,2013-03-31,2013-04-30 06:05:16+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,93700000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,33783000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,36420000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1637000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,71840000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1620000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,464000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,464000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,,totalassets,Total Assets,=,debit,usd,73924000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,5314000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5222000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9535000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,20071000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,18417000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,18417000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,38488000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,540162000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-504735000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,9000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,35436000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,35436000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,35436000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q2,,2013-06-30,2013-08-01 06:05:23+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,73924000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,25477000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,27907000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1358000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,54742000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1488000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,433000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,433000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,,totalassets,Total Assets,=,debit,usd,56663000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,7389000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5693000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12849000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,25931000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,16120000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,16120000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,42051000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,541856000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-527250000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,6000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,14612000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,14612000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,14612000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2013.0,Q3,,2013-09-30,2013-11-04 06:05:03+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,56663000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,52034000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,26753000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1605000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,80392000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,1408000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,384000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,384000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,,totalassets,Total Assets,=,debit,usd,82184000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,9302000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5810000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17253000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,32365000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,11520000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,75000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,11595000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,43960000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,613189000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-574969000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,4000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,38224000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,38224000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,38224000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2014.0,Q1,,2014-03-31,2014-05-08 06:10:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,82184000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,33255000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,43351000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1367000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,77973000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,855000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,564000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,564000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,,totalassets,Total Assets,=,debit,usd,79392000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,9263000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3738000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17919000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,30920000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,2299000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalnoncurrentliabilities,capitalleaseobligations,Capital Lease Obligations,+,credit,usd,33000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,2332000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,33252000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,704414000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-658280000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,6000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,46140000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,46140000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,46140000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2015.0,Q1,,2015-03-31,2015-05-07 06:04:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,79392000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,42815000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,9227000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,554000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,52596000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,374000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,,totalassets,Total Assets,=,debit,usd,52970000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,2332000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,744000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5563000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8639000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8639000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,757095000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-712768000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,4000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,44331000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,44331000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,44331000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q1,,2016-03-31,2016-05-10 08:31:55+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,52970000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,10756000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,32259000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1820000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,44835000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,103000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,,totalassets,Total Assets,=,debit,usd,44938000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,32000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,680000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,2652000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,3364000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,3364000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,757640000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-716147000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,81000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,41574000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,41574000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,41574000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2016.0,Q2,,2016-06-30,2016-07-20 16:01:16+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,44938000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,8215000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,31912000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,225000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,40352000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,5000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,,totalassets,Total Assets,=,debit,usd,40357000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2780000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,3126000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5906000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,5906000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,115693000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-81306000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,64000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,34451000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,34451000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,34451000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q1,,2017-03-31,2017-05-11 16:32:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,40357000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,34797000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,32369000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,781000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,67947000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,120000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,,totalassets,Total Assets,=,debit,usd,68067000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1285000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5151000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6436000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,6436000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,151248000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-89653000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,36000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,61631000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,61631000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,61631000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q2,,2017-06-30,2017-08-10 06:02:32+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,68067000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,12960000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,49177000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,583000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,62720000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,111000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,,totalassets,Total Assets,=,debit,usd,62831000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1400000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7123000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,8523000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,8523000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,152277000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-98016000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,47000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,54308000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,54308000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,54308000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2017.0,Q3,,2017-09-30,2017-11-09 06:10:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,62831000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,38125000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,144700000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,374000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,183199000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,279000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,,totalassets,Total Assets,=,debit,usd,183478000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1420000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4874000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6294000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,6294000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,290183000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-112825000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-174000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,177184000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,177184000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,177184000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q1,,2018-03-31,2018-05-08 06:03:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,183478000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,264861000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,225444000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,968000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,491273000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,255000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,,totalassets,Total Assets,=,debit,usd,491528000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,588000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,4848000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,5436000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,5436000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,605420000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-119285000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-43000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,486092000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,486092000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,486092000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q2,,2018-06-30,2018-08-07 06:08:56+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,491528000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,38046000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,450492000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,767000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,489305000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,244000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,,totalassets,Total Assets,=,debit,usd,489549000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,1031000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5611000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,6642000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,6642000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,610847000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-127797000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-143000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,482907000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,482907000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,482907000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2018.0,Q3,,2018-09-30,2018-11-06 06:03:30+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,489549000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,47493000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,430332000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,565000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,478390000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,240000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,930000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,930000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,,totalassets,Total Assets,=,debit,usd,479560000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4376000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,5778000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,302000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,10456000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,598000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,598000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,11054000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,622680000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-154352000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,178000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,468506000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,468506000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,468506000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q1,,2019-03-31,2019-05-08 06:03:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,479560000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,72508000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,393888000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,2389000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,468785000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,211000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,826000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,826000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,,totalassets,Total Assets,=,debit,usd,469822000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,446000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11564000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,306000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,12316000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,520000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,520000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,12836000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,630552000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-174051000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,485000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,456986000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,456986000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,456986000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q2,,2019-06-30,2019-08-07 06:03:10+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,469822000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,89486000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,364124000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,1712000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,455322000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,181000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,751000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,751000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,,totalassets,Total Assets,=,debit,usd,456254000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,773000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14381000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,310000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,15464000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,441000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,441000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,15905000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,635537000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-195480000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,292000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,440349000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,440349000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,440349000.0
Madrigal Pharmaceuticals Inc,MDGL,,0001157601,2019.0,Q3,,2019-09-30,2019-11-06 06:03:12+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,456254000.0
